Brian P. Angeli
Also at FMC Corp
About
Brian P. Angeli is a seasoned executive with extensive experience in strategic leadership and financial management. He joined FMC in 2014 and has since contributed to numerous significant initiatives and acquisitions, including the 2014 acquisition of Cheminova, the 2017 asset swap with DuPont, and the 2022 acquisition of BioPhero, as well as leading the separation of FMC's Lithium business through an IPO and subsequent spin-off.
Before his tenure at FMC, he developed his expertise in investment banking and financial diligence through roles at The Goldman Sachs Group and PricewaterhouseCoopers. These roles equipped him with a strong foundation in mergers and acquisitions in the industrial and natural resources sectors.
He is a Certified Public Accountant who holds a Bachelor of Science in Accounting and Finance from Boston College and an MBA from New York University Stern School of Business, underpinning his strong academic background with practical experience. His well-rounded career and commitment to strategic excellence underscore his contributions to FMC’s global operations and growth.